vimarsana.com

Latest Breaking News On - Precigen inc - Page 8 : vimarsana.com

Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission

– Designation is an important step toward bringing this potentially life-changing therapy to European patients – – EU Orphan Drug Designation is the first regulatory designation for a gorilla.

United-states
Stevenm-harasym
Helen-sabzevari
Exchange-commission
Prnewswire-precigen-inc
Precigen-inc
European-commission
Drug-administration
Nasdaq
Drug-designation-for-the-company
European-union
Committee-for-orphan-medicinal-products

Global Synthetic Biology Market Analysis Report, 2022 and 2023-2028: Rising Potential in Consumer Goods, Utilization of AI, Rising Demand for Bio-based Products, Increase in Synthetic Vaccines

/PRNewswire/ The "Global Synthetic Biology Market: Analysis By Product Type, By Technology, By Application, By End Users, By Region, Size and Trends with.

Japan
China
South-korea
United-states
India
Dublin
Ireland
America
Laura-wood
Thermo-fisher-scientific-inc
Danaher-corporation-integrated
Twist-bioscience-corporation

Precigen (PGEN) Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference

Precigen (PGEN) Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

California
United-states
San-francisco
Helen-sabzevari
Precigen-ultra
Drug-administration
Precigen-inc
Nasdaq
Company-ultra
Healthcare-conference
Breakthrough-therapy-designation
Orphan-drug-designation

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) rose sharply during Tuesday’s session after the company released topline data from.

China
New-jersey
United-states
Craig-ellis
Alpha-omega
Encephalopathies-dees
Argo-blockchain
Akso-health-group
Novartis
Soligenix-inc
Teva-pharmaceuticals
Brooge-energy

Director Jeffrey Kindler Sells 96,686 Shares of Precigen Inc

On December 28, 2023, Jeffrey Kindler, a Director at Precigen Inc (NASDAQ:PGEN), sold 96,686 shares of the company's stock, according to a recent SEC Filing.

Precigen-inc
Jeffrey-kindler
Precigen
Biotechnology-company

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.